Grants and Contributions

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

The objective of Stream 2 is to:
•Establish interdisciplinary networks that contribute to the rapid response, understanding, and coordination of SARS-CoV-2 variants research.

The objectives of Stream 1 are:
•Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and
•Generate timely evidence on SARS-CoV-2 variants that will show impact within 3-6 months and is relevant to biological, clinical, health system, and public health strategies.

Stream 1 applicants are strongly encouraged to consider maximizing impact by outlining how they intend to participate in:
1.The formation of a network (Stream 2) or participating in a network formed by another NPA (Stream 2); and,
2.The CIHR Network for Emerging Variants Research once established.

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.

Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.

As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework.

The objectives of Stream 1 are:
•Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and
•Generate timely evidence on SARS-CoV-2 variants that will show impact within 3-6 months and is relevant to biological, clinical, health system, and public health strategies.

Stream 1 applicants are strongly encouraged to consider maximizing impact by outlining how they intend to participate in:
1.The formation of a network (Stream 2) or participating in a network formed by another NPA (Stream 2); and,
2.The CIHR Network for Emerging Variants Research once established.

Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.

As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework.

• The CIHR Personalized Health Initiative, in partnership with CIHR’s Institutes of Aging (IA); Cancer Research (ICR), Gender and Health (IGH); Genetics (IG); and Health Services and Policy Research (IHSPR) will offer funding for applications that are determined to be specifically relevant to CIHR’s Personalized Health Initiative as described below.
o Building on the investments made through CIHR’s Personalized Health Initiative, this priority announcement aims to maximize these previous investments driving evidence-based implementation of Personalized Health approaches by increasing the sharing of real-world data application and data management at the international level.

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.